These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29190795)

  • 1. Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
    Andersen S; Richardsen E; Rakaee M; Bertilsson H; Bremnes R; Børset M; Busund LT; Slørdahl T
    PLoS One; 2017; 12(11):e0189000. PubMed ID: 29190795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.
    Vandsemb EN; Bertilsson H; Abdollahi P; Størkersen Ø; Våtsveen TK; Rye MB; Rø TB; Børset M; Slørdahl TS
    J Transl Med; 2016 Mar; 14():71. PubMed ID: 26975394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
    Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
    Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Zhou J; Wang S; Lu J; Li J; Ding Y
    Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer - a multicenter (in situ hybridization) study.
    Andersen S; Richardsen E; Moi L; Donnem T; Nordby Y; Ness N; Holman ME; Bremnes RM; Busund LT
    Sci Rep; 2016 Nov; 6():36573. PubMed ID: 27824162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.
    Ren T; Jiang B; Xing X; Dong B; Peng L; Meng L; Xu H; Shou C
    Pathol Oncol Res; 2009 Dec; 15(4):555-60. PubMed ID: 19247814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
    Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
    Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
    Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
    J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase of regenerating liver-3 induces angiogenesis by increasing extracellular signal-regulated kinase phosphorylation in endometrial adenocarcinoma.
    Ming J; Jiang Y; Jiang G; Zheng H
    Pathobiology; 2014; 81(1):1-7. PubMed ID: 23989302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
    Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
    Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.
    Richardsen E; Andersen S; Al-Saad S; Rakaee M; Nordby Y; Pedersen MI; Ness N; Grindstad T; Movik I; Dønnem T; Bremnes R; Busund LT
    PLoS One; 2017; 12(11):e0186852. PubMed ID: 29141018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer.
    Richardsen E; Andersen S; Melbø-Jørgensen C; Rakaee M; Ness N; Al-Saad S; Nordby Y; Pedersen MI; Dønnem T; Bremnes RM; Busund LT
    Sci Rep; 2019 Jan; 9(1):386. PubMed ID: 30674952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal expression of VEGF-A and VEGFR-2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy.
    Nordby Y; Andersen S; Richardsen E; Ness N; Al-Saad S; Melbø-Jørgensen C; Patel HR; Dønnem T; Busund LT; Bremnes RM
    Prostate; 2015 Nov; 75(15):1682-93. PubMed ID: 26268996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
    Wallin AR; Svanvik J; Adell G; Sun XF
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
    Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
    Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
    Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
    Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.